title: Abrogation of graft-versus-host disease following allotransplantation of cytotoxically deficient bone marrow across major histocompatibility barriers.
authors.affiliation: Diabetes Research Institute Cell Transplant Center, University of Miami School of Medicine, Florida 33136, USA.
authors.forename: G
authors.initials: G
authors.lastname: Selvaggi
authors.forename: L
authors.initials: L
authors.lastname: Inverardi
authors.forename: R B
authors.initials: RB
authors.lastname: Levy
authors.forename: M D
authors.initials: MD
authors.lastname: Brendel
authors.forename: J
authors.initials: J
authors.lastname: Spielman
authors.forename: D H
authors.initials: DH
authors.lastname: Mintz
authors.forename: E R
authors.initials: ER
authors.lastname: Podack
authors.forename: C
authors.initials: C
authors.lastname: Ricordi
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D054353:Perforin